Similar Stories
Sources
- Pearl Freier
Oran, age 13, is part of the CADET project - a series of UK trials assessing safety & effectiveness of deep brain stimulation for severe epilepsy. The Picostim neurotransmitter is made by UK company Amber Therapeutics & it has also been used to treat Parkinson's disease patients.… https://t.co/KIjvJtdOI4
- Pearl Freier
Oran has Lennox-Gastaut syndrome, a treatment-resistant form of epilepsy & diagnosed at age 3. The surgery occurred last Oct as part of a trial at @GreatOrmondSt in London before Oran turned 13. His mother said he has “much better quality of life" since the trial started. He's… https://t.co/KIjvJtdOI4
- Pearl Freier
A boy with severe epilepsy has become the 1st patient globally to trial a new device fitted in their skull to control seizures. Reports say the neurostimulator has reduced Oran Knowlson’s daytime seizures by 80%. By @BBCFergusWalsh https://t.co/aAa59jaSoy
- BBC Somerset
A boy from Somerset with severe epilepsy has become the first patient in the world to trial a new device fitted in their skull to control seizures. https://t.co/ZFir6zjoW9
- David Blanchflower BSc
World first epilepsy device fitted in UK boy's skull. https://t.co/FRkG3Sh5Q9
- BBC News (UK)
World first epilepsy device fitted in UK boy's skull https://t.co/UvWJN72zsB
- NTV Kenya
Inside five-hour surgery to save boy https://t.co/Mpn9syuLjB https://t.co/3Eakyezgvj